{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:35:38Z","timestamp":1779341738367,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jsat.2021.108633","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T15:50:38Z","timestamp":1632757838000},"page":"108633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["\u201cI didn't feel like a number\u201d: The impact of nurse care managers on the provision of buprenorphine treatment in primary care settings"],"prefix":"10.1016","volume":"132","author":[{"given":"Nisha","family":"Beharie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marissa","family":"Kaplan-Dobbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adelya","family":"Urmanche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Paone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Harocopos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jsat.2021.108633_bb0005","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/archinternmed.2010.541","article-title":"Collaborative care of opioid-addicted patients in primary care using buprenorphine: Five-year experience","volume":"171","author":"Alford","year":"2011","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.jsat.2021.108633_bb0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.drugpo.2017.11.021","article-title":"A qualitative study comparing physician-reported barriers to treating addiction using buprenorphine and extended-release naltrexone in US office-based practices","volume":"54","author":"Andraka-Christou","year":"2018","journal-title":"International Journal of Drug Policy"},{"issue":"2","key":"10.1016\/j.jsat.2021.108633_bb0015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qualitative Research in Psychology"},{"key":"10.1016\/j.jsat.2021.108633_bb0020","series-title":"SocioCultural Research Consultants","year":"2018"},{"issue":"1","key":"10.1016\/j.jsat.2021.108633_bb0025","first-page":"3019","article-title":"Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians","volume":"15","author":"DeFlavio","year":"2015","journal-title":"Rural and Remote Health"},{"issue":"6","key":"10.1016\/j.jsat.2021.108633_bb0030","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1007\/s10461-009-9593-3","article-title":"From conceptualizing to measuring HIV stigma: A review of HIV stigma mechanism measures","volume":"13","author":"Earnshaw","year":"2009","journal-title":"AIDS and Behavior"},{"issue":"3","key":"10.1016\/j.jsat.2021.108633_bb0035","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jsat.2013.10.004","article-title":"Leaving buprenorphine treatment: Patients\u2019 reasons for cessation of care","volume":"46","author":"Gryczynski","year":"2014","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108633_bb0040","series-title":"Applied thematic analysis","author":"Guest","year":"2011"},{"issue":"6","key":"10.1016\/j.jsat.2021.108633_bb0045","doi-asserted-by":"crossref","first-page":"S230","DOI":"10.1016\/j.amepre.2017.12.022","article-title":"Policy pathways to address provider workforce barriers to buprenorphine treatment","volume":"54","author":"Haffajee","year":"2018","journal-title":"American Journal of Preventive Medicine"},{"key":"10.1016\/j.jsat.2021.108633_bb0050","series-title":"IBM Corp. Released 2017 (25.0)","year":"2017"},{"key":"10.1016\/j.jsat.2021.108633_bb0055","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2105\/AJPH.2020.306000","article-title":"Increasing access to buprenorphine in safety-net primary care clinics: the New York City buprenorphine nurse care manager initiative","volume":"111","author":"Kaplan-Dobbs","year":"2020","journal-title":"American Journal of Public Health"},{"issue":"4","key":"10.1016\/j.jsat.2021.108633_bb0060","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cct.2010.03.009","article-title":"Integrating depression and chronic disease care among patients with diabetes and\/or coronary heart disease: The design of the TEAMcare study","volume":"31","author":"Katon","year":"2010","journal-title":"Contemporary Clinical Trials"},{"key":"10.1016\/j.jsat.2021.108633_bb0065","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jsat.2015.06.010","article-title":"Office-based opioid treatment with buprenorphine (OBOT-B): Statewide implementation of the Massachusetts collaborative care model in community health centers","volume":"60","author":"LaBelle","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"5","key":"10.1016\/j.jsat.2021.108633_bb0070","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/add.13270","article-title":"Association between trajectories of buprenorphine treatment and emergency department and in-patient utilization","volume":"111","author":"Lo-Ciganic","year":"2016","journal-title":"Addiction"},{"issue":"1\u20133","key":"10.1016\/j.jsat.2021.108633_bb0075","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.drugalcdep.2008.08.003","article-title":"Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: Comparison at intake and 6 months later","volume":"99","author":"Madras","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.jsat.2021.108633_bb0080","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jsat.2006.11.009","article-title":"Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients","volume":"33","author":"Maremmani","year":"2007","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108633_bb0085","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugalcdep.2019.02.031","article-title":"Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort","volume":"200","author":"Morgan","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.jsat.2021.108633_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-020-00399-8","article-title":"\u201cThey look at us like junkies\u201d: Influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City","volume":"17","author":"Muncan","year":"2020","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.jsat.2021.108633_bb0105","series-title":"Prescription monitoring program (retrieved from New York City Department of Health and Mental Hygiene, Bureau of Alcohol and Drug Use Prevention Care and Treatment)","year":"2020"},{"key":"10.1016\/j.jsat.2021.108633_bb0110","series-title":"Unintentional drug poisoning (overdose) deaths in New York City in 2019 (Epi data brief (122))","author":"Nolan","year":"2020"},{"key":"10.1016\/j.jsat.2021.108633_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1609406919899220","article-title":"Intercoder reliability in qualitative research: Debates and practical guidelines","volume":"19","author":"O\u2019Connor","year":"2020","journal-title":"International Journal of Qualitative Methods"},{"issue":"3","key":"10.1016\/j.jsat.2021.108633_bb0120","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/01.MLR.0000053018.20700.56","article-title":"Utilization and cost impact of integrating substance abuse treatment and primary care","volume":"41","author":"Parthasarathy","year":"2003","journal-title":"Medical Care"},{"key":"10.1016\/j.jsat.2021.108633_bb0130","author":"Senate"},{"key":"10.1016\/j.jsat.2021.108633_bb0135","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.drugalcdep.2017.09.017","article-title":"Linking patients with buprenorphine treatment in primary care: Predictors of engagement","volume":"181","author":"Simon","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.jsat.2021.108633_bb0140","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/jurban\/79.4.571","article-title":"Beliefs about methadone in an inner-city methadone clinic","volume":"79","author":"Stancliff","year":"2002","journal-title":"Journal of Urban Health"},{"issue":"5","key":"10.1016\/j.jsat.2021.108633_bb0145","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1080\/02791072.2014.921743","article-title":"Patient perspectives on buprenorphine\/naloxone: A qualitative study of retention during the starting treatment with agonist replacement therapies (START) study","volume":"46","author":"Teruya","year":"2014","journal-title":"Journal of Psychoactive Drugs"},{"issue":"1\u20132","key":"10.1016\/j.jsat.2021.108633_bb0150","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drugalcdep.2013.02.018","article-title":"Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: Systematic review","volume":"131","author":"Van Boekel","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2021.108633_bb0155","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jsat.2016.12.010","article-title":"Long-term retention in office based opioid treatment with buprenorphine","volume":"74","author":"Weinstein","year":"2017","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"14","key":"10.1016\/j.jsat.2021.108633_bb0160","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1001\/jama.286.14.1715","article-title":"Integrating primary medical care with addiction treatment: A randomized controlled trial","volume":"286","author":"Weisner","year":"2001","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jsat.2021.108633_bb0165","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00006223-200307000-00008","article-title":"Exploring the audit trail for qualitative investigations","volume":"28","author":"Wolf","year":"2003","journal-title":"Nurse Educator"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221003597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221003597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:58:18Z","timestamp":1760039898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547221003597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":30,"alternative-id":["S0740547221003597"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108633","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cI didn't feel like a number\u201d: The impact of nurse care managers on the provision of buprenorphine treatment in primary care settings","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108633","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108633"}}